Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
AGC Biologics announced a new partnership with Allergy Therapeutics, the fully integrated specialty pharmaceutical company specializing in allergy vaccines. The CDMO has manufactured phase I clinical trial materials for Allergy Therapeutics’ novel ...
read more
Rokote Laboratories Finland Ltd and Exothera S.A. will collaborate to bring the intranasal coronavirus vaccine FINCoVac 2.0 to clinical Phase I/II trials. Exothera will finetune the industrialization of the FINCOVAC 2.0 process and manufacture ...
read more
ATCC has entered into an agreement with QIAGEN to provide them with sequencing data from its collection of cell lines, and animal and human biological materials. QIAGEN Digital Insights, the bioinformatics unit of QIAGEN, will establish a database ...
read more
Discovery Life Sciences™ has acquired the Gentest® business unit, part of Corning Incorporated's Life Sciences business. The acquisition of Gentest complements Discovery's recent acquisition of In Vitro ADMET Laboratories, LLC (IVAL) in December of ...
read more
Wednesday, April 06, 2022
Charles River Laboratories International, Inc. has acquired Explora BioLabs Holdings, Inc., a provider of contract vivarium research services.
read more
Wednesday, April 06, 2022
Celerion, a clinical research organization (CRO) to the biopharmaceutical industry, announced that it has made a significant investment in its ADME (Absorption, Distribution, Metabolism and Excretion) suite of services to meet continuously increasing...
read more
Wednesday, April 06, 2022
INCOG BioPharma Services, an Indiana-based contract development and manufacturing organization (CDMO) has completed the construction of its cleanroom production area within the new 90,000ft2 biopharma manufacturing site.
read more
Wednesday, April 06, 2022
Asymchem Laboratories (Tianjin) Co., Ltd. announced the company has completed construction of a new building at its Dunhua, China, production site. The expansion will add nearly 500m³ of batch capacity to meet demands for upcoming commercialization ...
read more
Grand River Aseptic Manufacturing (GRAM) announced that Bernie King has been appointed Chief Operating Officer, a new position within GRAM. King will report to Tom Ross, President and CEO of GRAM.
read more
PharmaZell and Novasep the closing of their merger, following exclusive negotiations initiated in September 2021. This strategic merger creates a technology driven, CDMO and API manufacturer.
read more
CoreRx, Inc., an industry leading CDMO with formulation development, analytical services and GMP manufacturing sites in Clearwater, Florida and San Rafael, California,
read more
Berkshire Sterile Manufacturing (BSM) purchased a new IMA lab-scale lyophilizer to support their lyophilization development studies – a service that was added in Q1 2022.
read more
Recipharm, a leading global contract development and manufacturing organisation (CDMO), today announces the closing of its acquisitions of advanced therapy CDMO Arranta Bio and virotherapy CDMO Vibalogics.
read more
Global pharmaceutical contract packaging organization (CPO), Tjoapack has announced the completion of its expansion plans following a €10m+ plus investment at its Etten-Leur facility in the Netherlands.
read more
CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has won the Citeline Award for Excellence in Innovation in Response to COVID-19 – Clinical Trial Activities.
read more